Clinical Trial Update: Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs [Phase 3]

View source ↗

Summary

A Phase 3 trial update for a thio- or preservative-free hepatitis B vaccine in children aged 11-15 completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (thio- or preservative-free)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-03-31